MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
24h
Current
Min
4.48
Max
6.05
Income | -14M -37M |
---|---|
Sales | 7.9M 38M |
EPS | -4.07 |
Profit margin | -98.215 |
Employees | 279 |
EBITDA | 8.9M -24M |
Recommendations | Buy |
---|---|
12 Months Forecast | +216.29% upside |
Market Cap | 19M 53M |
---|---|
Previous open | 2.18 |
Previous close | 5.88 |
By Acuity
50%
50%
183 / 371 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
5.9501 / 7.66 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
7 paź 2025, 16:58 UTC
BMW Trims 2025 View, Citing Weaker Performance in China
DJ
Read
7 paź 2025, 23:43 UTC
Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk
DJ
Read
7 paź 2025, 23:36 UTC
Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk
DJ
Read
7 paź 2025, 23:19 UTC
Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk
DJ
Read
7 paź 2025, 22:50 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
7 paź 2025, 22:50 UTC
RBNZ Should Take the Option of a Bigger Cut -- Market Talk
DJ
Read
7 paź 2025, 22:40 UTC
South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk
DJ
Read
7 paź 2025, 21:56 UTC
Global Equities Roundup: Market Talk
DJ
Read
7 paź 2025, 21:56 UTC
Australia Shares Set to Start Day Roughly Flat -- Market Talk
DJ
Read
7 paź 2025, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
7 paź 2025, 20:44 UTC
Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ
DJ
Read
7 paź 2025, 19:42 UTC
Treasury Yields Fall as Data Blackout Continues -- Market Talk
DJ
Read
7 paź 2025, 19:23 UTC
Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com
DJ
Read
7 paź 2025, 19:07 UTC
Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk
DJ
Read
7 paź 2025, 19:02 UTC
U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk
DJ
Read
7 paź 2025, 16:20 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Read
7 paź 2025, 16:20 UTC
Basic Materials Roundup: Market Talk
DJ
Read
7 paź 2025, 16:20 UTC
Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk
DJ
Read
7 paź 2025, 16:15 UTC
AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk
DJ
Read
7 paź 2025, 16:15 UTC
Global Commodities Roundup: Market Talk
DJ
Read
7 paź 2025, 15:37 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
7 paź 2025, 15:37 UTC
Markets for Canadian Aluminum Open Up Beyond U.S. -- Market Talk
DJ
Read
7 paź 2025, 15:33 UTC
Gold Rise Tied to Lower Confidence in Dollar Assets -- Market Talk
DJ
Read
7 paź 2025, 15:25 UTC
Canadian Mining Stocks Rally on U.S. Defense Dept. Deal -- Market Talk
DJ
Read
7 paź 2025, 15:15 UTC
Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk
DJ
Read
7 paź 2025, 15:04 UTC
Market Talk Roundup: Latest on U.S. Politics
DJ
Read
7 paź 2025, 15:04 UTC
Canadian Aluminum Exports Squeezed by Tariffs -- Market Talk
DJ
Read
7 paź 2025, 14:56 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
7 paź 2025, 14:56 UTC
U.S. Government Shutdown May Impact Release of Canadian Trade Data -- Market Talk
DJ
Read
7 paź 2025, 14:52 UTC
These Stocks Are Moving the Most Today: Tesla, AMD, Ford, Dell, IBM, AppLovin, Trilogy Metals, Aehr, and More -- Barrons.com
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 18.25 USD 216.29%
High 30 USD
Low 8 USD
Based on 5 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
5 ratings
3
Buy
2
Hold
0
Sell
Based on 5 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
No Evidence
There are no events.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$